How much did Acasti raise?

Acasti raised $7.5 Million in a funding round on September 25, 2023.

Where is Acasti based and how big is it?

Acasti is based in Laval, Quebec, Canada. Fundz records about 18 employees.

Who are the decision-makers at Acasti?

Fundz holds 1 contact at Acasti. Names and contact details are shown to Fundz members.

Acasti Pharma reported raising $7.5 Million in an initial SEC Form D filing, from an offering of $15.1 Million

PUBLIC · GRCEOct 10, 2023$7.5M of $15.1M raised

Amount Raised

$7.5 Million

$7.5 Million sold, per SEC Form D (first sale Sep 25, 2023)

Round Type

Venture

LavalBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Quick answer

Acasti raised $7.5 Million in a funding round, dated September 25, 2023. Acasti is based in Laval, Quebec, Canada.

How much did Acasti raise?: Acasti raised $7.5 Million in a funding round on September 25, 2023.
What does Acasti do?: Acasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases.
Where is Acasti based and how big is it?: Acasti is based in Laval, Quebec, Canada. Fundz records about 18 employees.
Who are the decision-makers at Acasti?: Fundz holds 1 contact at Acasti. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Acasti that raised within 45 days of this round, from Fundz verified event records.

Forward Therapeutics raised $50M (Series A) on November 8, 2023.
Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
DalCor Pharmaceuticals raised $80M (Series D) on September 13, 2023.
Gyre Therapeutics raised $5M on October 30, 2023.
Aligos Therapeutics raised $92M on October 25, 2023.
Azora Therapeutics, Inc. (DE) raised $4M (Seed) on October 19, 2023.

Who to call at Acasti, and when

A new round usually means Acasti is about to hire and buy. The teams that reach out first get the meeting.

An alert the day Acasti raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Acasti, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Acasti. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Acasti

Location

2572 boul. Daniel-Johnson

Laval, Quebec, Canada

About

Acasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company’s novel drug delivery technologies have the potential to improve the performance of currently marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery – all which could help to increase treatment compliance and improve patient outcomes. The Company is focused on well-understood diseases that are poorly served by available therapies or have no approved therapies. Acasti is initially targeting three underserved orphan diseases - Subarachnoid Hemorrhage (SAH), Ataxia Telangiectasia (A-T), and Postherpetic Neuralgia (PHN) – all with sizable patient populations and significant market opportunity. The Company’s three lead clinical assets have all been granted Orphan Drug Designation by the FDA providing seven years of marketing exclusivity post-launch in the United States and are protected by over 40 granted and pending patents.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Acasti raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

1 contact

Verified contacts5 people are listed at Acasti. We don't have their email yet.See plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for Acasti's next move

See what Strategic adds

Acasti raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.